Interestingly, inhibition of breast cancer stem cells by TGF-β1 was reported recently (Tang et al, 2007) and TGF-β1 signalling is functional in CD44+ breast cancer cells (Derynck et al, 2001). The gene discussed is TGFB1; the disease is breast carcinoma.